Drug therapy - Schizophrenia

被引：277

作者：

Kane, JM ^{[1
]}

机构：

[1] ALBERT EINSTEIN COLL MED, DEPT PSYCHIAT, BRONX, NY USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1996年 / 334卷 / 01期

关键词：

D O I：

10.1056/NEJM199601043340109

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：34 / 41

页数：8

共 101 条

[21]

CSERNANSKY JG, 1988, ARCH GEN PSYCHIAT, V45, P655

[22] DEPOT ANTIPSYCHOTIC-DRUGS - PLACE IN THERAPY (VOL 47, PG 741, 1994) [J].

DAVIS, JM ;

MATALON, L ;

WATANABE, MD .

DRUGS, 1994, 48 (04) :616-616

[23]

DAVIS JM, 1975, AM J PSYCHIAT, V132, P1237

[24] DEPOT ANTIPSYCHOTIC-DRUGS - PLACE IN THERAPY [J].

DAVIS, JM ;

METALON, L ;

WATANABE, MD ;

BLAKE, L .

DRUGS, 1994, 47 (05) :741-773

[25]

DAVIS JM, 1989, COMPREHENSIVE TXB PS, V5, P1591

[26]

DEVINSKY O, 1994, J CLIN PSYCHIAT, V55, P153

[27]

ERICKSEN S E, 1978, Psychopharmacology Bulletin, V14, P15

[28] DISTRIBUTION OF REMOXIPRIDE TO THE HUMAN BRAIN AND CENTRAL D2-DOPAMINE RECEPTOR-BINDING EXAMINED INVIVO BY PET [J].

FARDE, L ;

VONBAHR, C .

ACTA PSYCHIATRICA SCANDINAVICA, 1990, 82 :67-&

[29]

FARDE L, 1992, ARCH GEN PSYCHIAT, V49, P538

[30] CLOZAPINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES, AND THERAPEUTIC USE IN SCHIZOPHRENIA [J].

FITTON, A ;

HEEL, RC .

DRUGS, 1990, 40 (05) :727-747

← 1 2 3 4 5 6 7 8 9 10 →